BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 18485383)

  • 1. A novel nomogram to predict the probability of prostate cancer on repeat biopsy.
    Benecchi L; Pieri AM; Melissari M; Potenzoni M; Pastizzaro CD
    J Urol; 2008 Jul; 180(1):146-9. PubMed ID: 18485383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is race a positive predictor of cancer on repeat prostate biopsy?
    Yanke BV; Salzhauer EW; Colon I
    J Urol; 2006 Sep; 176(3):1114-7. PubMed ID: 16890704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of a nomogram for predicting positive repeat biopsy for prostate cancer.
    Yanke BV; Gonen M; Scardino PT; Kattan MW
    J Urol; 2005 Feb; 173(2):421-4. PubMed ID: 15643192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and external validation of an extended repeat biopsy nomogram.
    Chun FK; Briganti A; Graefen M; Porter C; Montorsi F; Haese A; Scattoni V; Borden L; Steuber T; Salonia A; Schlomm T; Latchemsetty K; Walz J; Kim J; Eichelberg C; Currlin E; Ahyai SA; Erbersdobler A; Valiquette L; Heinzer H; Rigatti P; Huland H; Karakiewicz PI
    J Urol; 2007 Feb; 177(2):510-5. PubMed ID: 17222622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A nomogram for predicting low-volume/low-grade prostate cancer: a tool in selecting patients for active surveillance.
    Nakanishi H; Wang X; Ochiai A; Trpkov K; Yilmaz A; Donnelly JB; Davis JW; Troncoso P; Babaian RJ
    Cancer; 2007 Dec; 110(11):2441-7. PubMed ID: 17932909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of prostate cancer on extended biopsy in patients with high-grade prostatic intraepithelial neoplasia: a multivariate analysis model.
    Abdel-Khalek M; El-Baz M; Ibrahiem el-H
    BJU Int; 2004 Sep; 94(4):528-33. PubMed ID: 15329106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The number of cores positive for high grade prostatic intraepithelial neoplasia on initial biopsy is associated with prostate cancer on second biopsy.
    De Nunzio C; Trucchi A; Miano R; Stoppacciaro A; Fattahi H; Cicione A; Tubaro A
    J Urol; 2009 Mar; 181(3):1069-74; discussion 1074-5. PubMed ID: 19150546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development, validation, and head-to-head comparison of logistic regression-based nomograms and artificial neural network models predicting prostate cancer on initial extended biopsy.
    Kawakami S; Numao N; Okubo Y; Koga F; Yamamoto S; Saito K; Fujii Y; Yonese J; Masuda H; Kihara K; Fukui I
    Eur Urol; 2008 Sep; 54(3):601-11. PubMed ID: 18207312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The presence of prostate cancer on saturation biopsy can be accurately predicted.
    Ahyai SA; Isbarn H; Karakiewicz PI; Chun FK; Reichert M; Walz J; Steuber T; Jeldres C; Schlomm T; Heinzer H; Salomon G; Budäus L; Perrotte P; Huland H; Graefen M; Haese A
    BJU Int; 2010 Mar; 105(5):636-41. PubMed ID: 20149204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a nomogram to predict probability of positive initial prostate biopsy among Japanese patients.
    Suzuki H; Komiya A; Kamiya N; Imamoto T; Kawamura K; Miura J; Suzuki N; Nakatsu H; Hata A; Ichikawa T
    Urology; 2006 Jan; 67(1):131-6. PubMed ID: 16413348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can the number of cores with high-grade prostate intraepithelial neoplasia predict cancer in men who undergo repeat biopsy?
    Naya Y; Ayala AG; Tamboli P; Babaian RJ
    Urology; 2004 Mar; 63(3):503-8. PubMed ID: 15028446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a new nomogram for predicting the probability of a positive initial prostate biopsy in Japanese patients with serum PSA levels less than 10 ng/mL.
    Kawamura K; Suzuki H; Kamiya N; Imamoto T; Yano M; Miura J; Shimbo M; Suzuki N; Nakatsu H; Ichikawa T
    Int J Urol; 2008 Jul; 15(7):598-603. PubMed ID: 18462353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate cancers diagnosed at repeat biopsy are smaller and less likely to be high grade.
    Tan N; Lane BR; Li J; Moussa AS; Soriano M; Jones JS
    J Urol; 2008 Oct; 180(4):1325-9; discussion 1329. PubMed ID: 18707706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and external validation of an extended 10-core biopsy nomogram.
    Chun FK; Briganti A; Graefen M; Montorsi F; Porter C; Scattoni V; Gallina A; Walz J; Haese A; Steuber T; Erbersdobler A; Schlomm T; Ahyai SA; Currlin E; Valiquette L; Heinzer H; Rigatti P; Huland H; Karakiewicz PI
    Eur Urol; 2007 Aug; 52(2):436-44. PubMed ID: 17010505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Saturation technique does not decrease cancer detection during followup after initial prostate biopsy.
    Lane BR; Zippe CD; Abouassaly R; Schoenfield L; Magi-Galluzzi C; Jones JS
    J Urol; 2008 May; 179(5):1746-50; discussion 1750. PubMed ID: 18343412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. History of malignancy is a predictor of prostate cancer detection: incorporation into a pre-biopsy nomogram.
    Kawakami S; Koga F; Fujii Y; Saito K; Yamamoto S; Tatokoro M; Yonese J; Kageyama Y; Fukui I; Kihara K
    Int J Urol; 2008 Dec; 15(12):1055-60. PubMed ID: 19054174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nomogram prediction for prostate cancer and aggressive prostate cancer at time of biopsy: utilizing all risk factors and tumor markers for prostate cancer.
    Nam RK; Toi A; Klotz LH; Trachtenberg J; Jewett MA; Loblaw A; Pond GR; Emami M; Sugar L; Sweet J; Narod SA
    Can J Urol; 2006 Apr; 13 Suppl 2():2-10. PubMed ID: 16672122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of prostate cancer prevention trial risk calculator in a contemporary cohort screened for prostate cancer and diagnosed by extended prostate biopsy.
    Nguyen CT; Yu C; Moussa A; Kattan MW; Jones JS
    J Urol; 2010 Feb; 183(2):529-33. PubMed ID: 20006887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and internal validation of a Prostate Health Index based nomogram for predicting prostate cancer at extended biopsy.
    Lughezzani G; Lazzeri M; Larcher A; Lista G; Scattoni V; Cestari A; Buffi NM; Bini V; Guazzoni G
    J Urol; 2012 Oct; 188(4):1144-50. PubMed ID: 22901589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The proportion of cores with high-grade prostatic intraepithelial neoplasia on extended-pattern needle biopsy is significantly associated with prostate cancer on site-directed repeat biopsy.
    Akhavan A; Keith JD; Bastacky SI; Cai C; Wang Y; Nelson JB
    BJU Int; 2007 Apr; 99(4):765-9. PubMed ID: 17378840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.